electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million
Stocks in this Quantisnow insightHealth Care
Historical context for ECOR
Across the 4 sessions after earlier ECOR headlines, the stock closed higher 3 times and lower 1 times, with a median move of 1.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ECOR | SPY |
|---|---|---|---|
| Dec 2, 2025 | TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen | -0.4% | +0.2% |
| Nov 11, 2025 | electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum | +1.3% | +0.2% |
| Nov 6, 2025 | electroCore Announces Third Quarter 2025 Financial Results | +23.2% | -1.1% |
| Oct 23, 2025 | electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025 | +1.4% | +0.6% |
Quantisnow market dataNASDAQ
ECOR
electroCore Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2018
Get push alerts for ECOR
Full ECOR profile on Quantisnow Follow ECOR and get a push notification the moment its next story breaks.